In Silico Clinical Trials Market to Grow at a CAGR of 12.28% During the Forecast Period
Growing prevalence of various diseases is driving the growth in global In Silico Clinical Trials market in the forecast period. According to TechSci Research report, “ In Silico Clinical Trials Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2017-2027 ”, the global In Silico Clinical Trials market stood at USD2743.64 million in 2021 and is expected to grow at a CAGR of 12.28% during the forecast period. This can be ascribed to the fact that in silico clinical trials help in saving time, costs and resources. Additionally, In Silico Clinical Trials are readily approved and authorized by the US Food and Drug Administration (FDA) thereby supporting the market growth through 2027F. Additionally, adoption of Electronic Health Records (EHR) provides ample opportunities to enhance patient care as it contains a wealth of clinical data which can be used to identify the potential clinical trials participants. There is a vast adoption of...